DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,631,009 | -3.5% | 6,574 | -6.7% | 0.23% | +6.4% |
| Q2 2023 | $1,690,320 | -74.1% | 7,043 | -72.8% | 0.22% | -75.3% |
| Q1 2023 | $6,524,559 | +86146.6% | 25,887 | -9.2% | 0.89% | -9.1% |
| Q4 2022 | $7,565 | -99.9% | 28,502 | -3.2% | 0.98% | -4.7% |
| Q3 2022 | $7,606,000 | +0.6% | 29,448 | -1.3% | 1.03% | +6.4% |
| Q2 2022 | $7,563,000 | -0.8% | 29,830 | +14.8% | 0.97% | +17.7% |
| Q1 2022 | $7,621,000 | -8.7% | 25,981 | +2.4% | 0.82% | -1.8% |
| Q4 2021 | $8,351,000 | +46.0% | 25,381 | +35.1% | 0.84% | +42.7% |
| Q3 2021 | $5,719,000 | +30.9% | 18,786 | +15.4% | 0.59% | +45.4% |
| Q2 2021 | $4,369,000 | +72.8% | 16,281 | +45.0% | 0.40% | +59.9% |
| Q1 2021 | $2,528,000 | -51.7% | 11,231 | -52.4% | 0.25% | -47.1% |
| Q4 2020 | $5,239,000 | +181.8% | 23,583 | +173.2% | 0.48% | +183.3% |
| Q3 2020 | $1,859,000 | +63.9% | 8,633 | +34.6% | 0.17% | +54.1% |
| Q2 2020 | $1,134,000 | +388.8% | 6,414 | +156.6% | 0.11% | +473.7% |
| Q4 2015 | $232,000 | – | 2,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |